Harbour Investments »

Eliem Therapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.0k 2.0k 2.01

More positions owned by Harbour Investments

Vanguard Index Fds &p 500 Etf Shs (VOO)
Invesco Qqq Tr Nit Ser 1 (QQQ)
First Tr Exchange-traded Mid Risng Etf (SDVY)
First Tr Exchng Traded Fd Vi T Vest Laddered (BUFR)
Ishares Tr Ore S&p Mcp Etf (IJH)
First Tr Exchng Traded Fd Vi Mith Unconstrai (UCON)
Apple Om (AAPL)
Ishares Tr Ore S&p500 Etf (IVV)
First Tr Exchange-traded Ap Strength Etf (FTCS)
Schwab Strategic Tr S Lrg Cap Etf (SCHX)
Spdr S&p 500 Etf Tr R Unit (SPY)
Spdr Series Trust Ortfolio S&p500 (SPLG)
Schwab Strategic Tr S Dividend Eq (SCHD)
Nvidia Corporation Om (NVDA)
Capital Grp Fixed Incm Etf T Ore Plus Incm (CGCP)

View all positions for Harbour Investments

Top funds holding Eliem Therapeutics

RA Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Tang Capital Management
BlackRock
Peapod Lane Capital
Cantor Fitzgerald, L. P.
Renaissance Technologies
Deep Track Capital
Alyeska Investment Group
Millennium Management
Nan Fung Trinity
Sphera Funds Management
Geode Capital Management

View all funds holding Eliem Therapeutics